It has been emphasized recently that there is a strong association between atrial fibrillation and inflammation. Rheumatoid arthritis (RA), characterized by ongoing inflammatory activity, can increase the risk of atrial arrhythmia. P-wave dispersion has been encountered as a risk factor for atrial fibrillation and the effect of inflammation on P-wave dispersion has not been studied thoroughly. The aim of this study was to examine the effect of ongoing inflammatory activity in RA on P-wave dispersion. The study comprised 82 patients diagnosed with RA and 41 healthy volunteers as controls. Systolic functions of all participants were evaluated by echocardiography. Maximum P-wave duration and dispersion were calculated and found to be significantly increased in the RA group compared with the healthy controls. These parameters were also significantly correlated with C-reactive protein levels. The findings of this study suggest that RA may be associated with increases in P-wave dispersion and maximum P-wave duration, and that this association may result from ongoing inflammation.
LawrenceRCHelmickCGArnettFC: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum1998; 41: 778–799.
2.
GabrielSE: The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am2001; 27: 269–281.
3.
GabrielSECrowsonCSO'FallonWM: Comorbidity in arthritis. J Rheumatol1999; 26: 2475–2479.
4.
MikulsTRSaagKG: Comorbidity in rheumatoid arthritis. Rheum Dis Clin North Am2001; 27: 283–303.
5.
BaconPATownendJN: Nails in the coffin: Increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis [editorial]. Arthritis Rheum2001; 44: 2707–2710.
6.
VandenbrouckeJPHazevoetHMCatsA: Survival and cause of death in rheumatoid arthritis: A 25-year prospective followup. J Rheumatol1984; 11: 158–161.
7.
MutruOLaaksoMIsomakiH: Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology1989; 76: 71–77.
8.
DaneshJWhincupPWalkerM: Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. BMJ2000; 321: 199–204.
9.
SzmitkoPEWangCHWeiselRD: New markers of inflammation and endothelial cell activation: Part I. Circulation2003; 108: 1917–1923.
10.
RostNSWolfPAKaseCS: Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham study. Stroke2001; 32: 2575–2579.
11.
BoosCJAndersonRALipGY: Is atrial fibrillation an inflammatory disorder?Eur Heart J2006; 27: 136–149.
12.
KirwanJR: Links between radiological change, disability, and pathology in rheumatoid arthritis. J Rheumatol2001; 28: 881–886.
13.
DilaverisPEGialafosEJSiderisSK: Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J1998; 135: 733–738.
14.
DilaverisPEGialafosEJAndrikopoulosGK: Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol2000; 23: 352–358.
15.
ArnettFCEdworthySMBlochDA: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988; 31: 315–324.
16.
RogersEWFeigenbaumHWeymanAE: Echocardiography for quantification of cardiac chambers. In: Progress in Cardiology (YuPNGoodwinJF, eds). Philadelphia: Lea & Febiger, 1979; pp 807–809.
17.
MackiewiczASperoffTGanapathiMK: Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol1991; 146: 3032–3037.
18.
RidkerPM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation2003; 107: 363–369.
19.
ChungMKMartinDOSprecherD: C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation2001; 104: 2886–2891.
20.
MadjidMAwanIWillersonJT: Leukocyte count and coronary heart disease: Implications for risk assessment. J Am Coll Cardiol2004; 44: 1945–1956.
21.
van der BijlAEAllaartCFVan VugtJ: Rheumatoid vasculitis treated with infiximab. J Rheumatol2005; 32: 1607–1609.
22.
QuinnMAConaghanPGO'ConnorPJ: Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum2005; 52: 27–35.
23.
BruinsPte VelthuisHYazdanbakhshAP: Activation of the complement system during and after cardiopulmonary bypass surgery. Post-surgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation1997; 96: 3542–3548.
24.
MarnellLMoldCDu ClosTW: C-reactive protein: Ligands, receptors and role in inflammation. Clin Immunol2005; 117: 104–111.
25.
KleinRMVesterEGBrehmMU: Inflammation of the myocardium as an arrhythmia trigger. Z Kardiol2000; 89 (suppl 3): 24–35.
26.
MaloufJFKanagalaRAl AtawiFO: High sensitivity C-reactive protein: A novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol2005; 46: 1284–1287.
27.
SpodickDH: Arrhythmias during acute pericarditis. A prospective study of 100 consecutive cases. JAMA1976; 235: 39–41.
28.
TurhanHYetkinESahinO: Comparison of P-wave duration and dispersion in patients aged ≥ 65 years with those aged ≤ 45 years. J Electrocardiol2003; 36: 321–326.
29.
SenenKTurhanHErbayA Riza: P-wave duration and P-wave dispersion in patients with dilated cardiomyopathy. Eur J Heart Fail2004; 6: 567–569.
30.
TukekTAkkayaVAtilganD: Effect of left atrial size and function on P-wave dispersion: A study in patients with paroxysmal atrial fibrillation. Clin Cardiol2001; 24: 676–680.
31.
TukekTAkkayaVDemirelS: Effect of Valsalva maneuver on surface electrocardiographic P-wave dispersion in paroxysmal atrial fibrillation. Am J Cardiol2000; 85: 896–899.
